Sachin Kumar Singh

InstitutionLovely Professional University
AddressPunjab
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in June 2021
    All Publications
    Bar chart showing 55 publications over 12 distinct years, with a maximum of 11 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gupta G, S R, Singh Y, Thangavelu L, Singh SK, Dureja H, Chellappan DK, Dua K. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics. Drug Dev Res. 2021 11; 82(7):880-882. PMID: 34323298.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635. PMID: 34312598.
      Citations: 1     
    3. Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Rama Raju Allam VS, Jha NK, Chellappan DK, Dua K, Gupta G. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021 Aug 25; 345:109568. PMID: 34181887.
      Citations: 3     Fields:    Translation:HumansAnimals
    4. Chan Y, Ng SW, Singh SK, Gulati M, Gupta G, Chaudhary SK, Hing GB, Collet T, MacLoughlin R, Löbenberg R, Oliver BG, Chellappan DK, Dua K. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci. 2021 Sep 01; 280:119744. PMID: 34174324.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    5. Alnuqaydan AM, Almutary AG, Sukamaran A, Yang BTW, Lee XT, Lim WX, Ng YM, Ibrahim R, Darmarajan T, Nanjappan S, Chellian J, Candasamy M, Madheswaran T, Sharma A, Dureja H, Prasher P, Verma N, Kumar D, Palaniveloo K, Bisht D, Gupta G, Madan JR, Singh SK, Jha NK, Dua K, Chellappan DK. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech. 2021 Jun 08; 22(5):173. PMID: 34105037.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    6. Anand K, Vadivalagan C, Joseph JS, Singh SK, Gulati M, Shahbaaz M, Abdellattif MH, Prasher P, Gupta G, Chellappan DK, Dua K. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact. 2021 Aug 01; 344:109497. PMID: 33991505.
      Citations:    Fields:    Translation:HumansCells
    7. Singh Y, Ali H, Alharbi KS, Almalki WH, Kazmi I, Al-Abbasi FA, Anand K, Dureja H, Singh SK, Thangavelu L, Chellappan DK, Dua K, Gupta G. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021 09; 82(6):784-788. PMID: 33687087.
      Citations:    Fields:    Translation:Humans
    8. Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209. PMID: 33464535.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    9. Awasthi A, Vishwas S, Corrie L, Kumar R, Khursheed R, Kaur J, Kumar R, Arya KR, Gulati M, Kumar B, Singh SK, Pandey NK, Wadhwa S, Kumar P, Kapoor B, Gupta RK, Kumar A. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath. Eur J Pharmacol. 2020 Oct 05; 884:173381. PMID: 32721449.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health